Teva

Teva was founded in 1901 and is headquartered in Israel. Its current portfolio spans 3,500 different products, and it manufactures nearly 85 billion tablets and capsules each year across 65 manufacturing sites worldwide. Teva ranks among the world's leading pharmaceutical companies, with an active presence in 60 markets. Its medicines are taken by 200 million people every day.

We assessed the feasibility of utilizing high-organic-content waste and by-products — sludge, fermentation broths, and solvent-containing liquid waste — generated at TEVA Zrt.'s Debrecen and Sajóbábony plants, in a new, dedicated biogas facility. Following data collection and site surveys, we carried out sampling and laboratory biogas yield testing. We also ran an on-site pilot to investigate the disintegration of biological sludge from the industrial wastewater pre-treatment system at the client's Debrecen plant, testing the effectiveness of an electrokinetic disintegration unit over six weeks. We delivered the resulting biogas plant designs — backed by both on-site and laboratory measurements — as a feasibility study covering separate biogas plant concepts for the Sajóbábony and Debrecen sites. At the Debrecen site, the planned technical scope also included a wastewater heat pump and a low-temperature sludge dryer alongside the gas engine.